Kilitch Drugs (India) Ltd.

₹215.11

14.5 (7.2%)

KILITCH Share Price

Pharmaceuticals & Biotechnology

As on November 13, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 753.07 Cr

P/E Ratio24.93

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	200.99	Bullish
10-DMA	202.55	Bullish
20-DMA	205.76	Bullish
50-DMA	209.05	Bullish
100-DMA	195.66	Bullish
200-DMA	178.53	Bullish

Historical Performance

1 Year

17%

3 Years

35.8%

5 Years

154.9%

10 Years

967.1%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	2,355	1,983	1,544	1,396	1,142
Total Expenditure	1,981	1,666	1,301	1,219	1,037
Other Income	112	112	45	29	29
Operating Profit	486	429	287	206	134
Interest	63	53	60	51	13
Depreciation	36	31	33	36	25
Profit Before Tax	387	345	194	120	96
Consolidated Net Profit	302	267	146	104	74
Adjusted EPS	9	8	4	3	2

Compounded Sales Growth

10 Years:62.2

5 Years:28

3 Years:11

TTM:3.5

Compounded Profit Growth

10 Years:-1.4

5 Years:52.4

3 Years:23.6

TTM:2.5

Stock Price CAGR

10 Years:26.7

5 Years:20.6

3 Years:10.7

TTM:19.7

Return on Equity

10 Years:-3.3

5 Years:2.3

3 Years:4.4

last year:8.6

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	350	161	161	156	156
Total Reserves	2,443	1,859	1,599	1,307	1,206
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	547	251	-24	-19	-12
Other Current Liabilities	31	3	3	2	6
Short Term Borrowings	301	217	316	222	204
Total Liabilities	4,532	3,099	2,375	2,175	2,083
Capital Work in Progress	1,400	473	60	36	32
Long Term Loans & Advances	14	14	7	6	5
Currents Investments	520	495	494	392	472
Short Term Loans and Advances	210	80	80	104	100
Total Current Assets	2,222	1,739	1,460	1,264	1,141
Total Assets	4,532	3,099	2,375	2,175	2,083
Adjusted Book Value	80	61	107	94	87

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a moderate PE of 24.93, suggesting fair valuation relative to earnings.
Over the last three years, the stock delivered a moderate 3-year price CAGR of 10.7%, reflecting average market performance.
The stock carries a beta of 0.9, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹486 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹2355 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1197217.2

No. of Shares: 5566 (Approx)

Performance:19.7%

197217.2

NIFTY Performance: -3%

1 day Top Gainers